Abbott
Abbott enrolls first patients in Zomaxx Europe clinical trial
Published in Aging and Elder Health Week, June 18th, 2006
The Zomaxx Europe study is a single-arm trial that will evaluate the safety and performance of the Zomaxx zotarolimus-eluting stent in patients with single- or two-vessel coronary artery disease, representing an important step toward broadening the complexity of patients treated with Zomaxx. The study will include approximately 900 patients at up to 60 sites throughout Europe with a primary endpoint of target lesion revascularization (TLR) at 9 months.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Amarin Corp. plc
Amarin acquires Parkinson disease drug candidate - Axonyx, Inc.
Axonyx completes multiple-dose phase I study of Posiphen - Breast Cancer
Weight gain in women increases risk of all types of breast cancer - Campus Biomedico University, Rome
Researchers from Italy and France report recent findings in lung cancer - Dementia
Characteristics of caregivers may increase symptoms in dementia patients - Erasmus Medical Center, Rotterdam
Researchers from Erasmus Medical Center, Rotterdam publish new findings - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
